BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37302809)

  • 1. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
    Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
    Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.
    Ye M; Hu C; Chen T; Yu P; Chen J; Lu F; Xu L; Zhong Y; Yan L; Kan J; Bai J; Li X; Tian Y; Tang Q
    Int J Biol Sci; 2023; 19(10):3115-3127. PubMed ID: 37416772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway.
    Xu Z; Li C; Qu H; Li H; Gu Q; Xu J
    Tumour Biol; 2017 Jun; 39(6):1010428317711324. PubMed ID: 28639885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid synthase contributes to epithelial-mesenchymal transition and invasion of salivary adenoid cystic carcinoma through PRRX1/Wnt/β-catenin pathway.
    Zhang WL; Wang SS; Jiang YP; Liu Y; Yu XH; Wu JB; Wang K; Pang X; Liao P; Liang XH; Tang YL
    J Cell Mol Med; 2020 Oct; 24(19):11465-11476. PubMed ID: 32820613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms.
    Gu D; Ye M; Zhu G; Bai J; Chen J; Yan L; Yu P; Lu F; Hu C; Zhong Y; Liu P; He Q; Tang Q
    J Transl Med; 2024 Jan; 22(1):93. PubMed ID: 38263056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
    Zhang W; Huang J; Tang Y; Yang Y; Hu H
    Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncNEN885 inhibits epithelial-mesenchymal transition by partially regulation of Wnt/β-catenin signalling in gastroenteropancreatic neuroendocrine neoplasms.
    Wei YL; Hua J; Liu XY; Hua XM; Sun C; Bai JA; Tang QY
    Cancer Sci; 2018 Oct; 109(10):3139-3148. PubMed ID: 30033597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway.
    Wang H; Xi Q; Wu G
    Cancer Med; 2016 Jul; 5(7):1599-606. PubMed ID: 27139420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma.
    Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N
    Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner.
    Chen J; Ye M; Bai J; Gong Z; Yan L; Gu D; Hu C; Lu F; Yu P; Xu L; Wang Y; Tian Y; Tang Q
    J Transl Med; 2023 Oct; 21(1):741. PubMed ID: 37858219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM96A and FAM96B function as new tumor suppressor genes in breast cancer through regulation of the Wnt/β-catenin signaling pathway.
    Zhang DD; Sun XL; Liang ZY; Wang XY; Zhang LN
    Life Sci; 2022 Nov; 308():120983. PubMed ID: 36165859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAFB2 Inhibits the Progression of Breast Cancer by Suppressing the Wnt/β-Catenin Signaling Pathway via NFAT5.
    Zhen H; Yao Y; Yang H
    Mol Biotechnol; 2023 Sep; 65(9):1465-1475. PubMed ID: 36652182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
    Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
    Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
    Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
    Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.